Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion type Assertion NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_head.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion description "[Neutralization of RSV-CM with antibodies to interferon (IFN)-beta largely blocked TAP1/LMP2/LMP7 expression, whereas anti-interleukin-1 antibodies were without effect, and recombinant IFN-beta increased TAP1/LMP2/LMP7 expression to levels produced by RSV-CM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_provenance.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion evidence source_evidence_literature NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_provenance.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion SIO_000772 11159003 NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_provenance.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion wasDerivedFrom befree-2016 NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_provenance.
- NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_assertion wasGeneratedBy ECO_0000203 NP305506.RA_V6lynC9SpGT-olv4lbxCeSngoybSi4XC3M82lL9NC0130_provenance.